Publications database

Displaying 1 - 10 of 925

Cover of the European Drug Report 2023 commentary

European Drug Report

Clone of Uimastiolukord Euroopas kuni 2023. aastani – tekkivate ohtude ja uute arengute ülevaade ja hinnang (Euroopa uimastiprobleemide aruanne 2023)

Sellel leheküljel kasutatakse uusimaid kättesaadavaid andmeid, et anda ülevaade praegusest olukorrast ja tekkivatest uimastiprobleemidest, mis mõjutavad Euroopat, keskendudes ajavahemikule kuni 2022. aasta lõpuni. Siin esitatud analüüsis esitatakse mitu arengut, millel võib olla...

Cover of the European Drug Report 2023 commentary

European Drug Report

Uimastiolukord Euroopas kuni 2023. aastani – tekkivate ohtude ja uute arengute ülevaade ja hinnang (Euroopa uimastiprobleemide aruanne 2023)

Sellel leheküljel kasutatakse uusimaid kättesaadavaid andmeid, et anda ülevaade praegusest olukorrast ja tekkivatest uimastiprobleemidest, mis mõjutavad Euroopat, keskendudes ajavahemikule kuni 2022. aasta lõpuni. Siin esitatud analüüsis esitatakse mitu arengut, millel võib olla...

Cover of the European Drug Report 2023 NPS

European Drug Report

Uued psühhoaktiivsed ained – praegune olukord Euroopas (Euroopa uimastiprobleemide aruanne 2023)

Uute psühhoaktiivsete ainete turgu iseloomustab sellesse valdkonda tekkinud ainete arvukus ning asjaolu, igal aastal avastatakse üha uusi ühendeid. Sellelt lehelt leiate ülevaate uute psühhoaktiivsete ainete olukorrast Euroopas, mida toetavad konfiskeerimisandmed ja ELi...

cover of report The future of drug monitoring in Europe until 2030: a report summarising the findings and lessons learnt from the EMCDDA's future's study

Technical reports

The future of drug monitoring in Europe until 2030: A report summarising the findings and lessons learnt from the EMCDDA’s ‘futures study’

Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring...

Technical reports

European Questionnaire on Drug Use among People living in prison (EQDP) (Long version)

This is the final version of the questionnaire on drug use among prisoners at European level. The questionnaire is the results of several years of work in the field of drugs and...

Perspectives on Drugs (PODs)

The EU drugs strategy: a model for common action

On the basis of an external evaluation of the EU drugs strategy 2005-12, on 7 December 2012 the Justice and Home Affairs Council of the European Union endorsed a new EU drugs...

Manuals and guidelines

Financial regulation of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

This regulation lays down the essential financial rules for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). It is based on and does not depart from the Commission Delegated Regulation...

Benzodiazepines POD's cover

Perspectives on Drugs (PODs)

The misuse of benzodiazepines among high-risk opioid users in Europe (Perspectives on drugs)

Benzodiazepines are a widely prescribed group of medicines with a range of clinical uses, including the treatment of anxiety and insomnia and the management of alcohol withdrawal. For a number of reasons...

Drugnet Europe 99

In this issue: Lisbon Addictions 2017 | New EMCDDA guide on responses | EMCDDA responds to increasing risks posed by new fentanils | IPA5 project draws to a close | Supporting global...

Budget 2017

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...